Canadian Pacific Kansas City Limited Common Shares vs Zimmer Biomet Holdings Inc — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $84.17 (market cap $73.98B), while Zimmer Biomet Holdings Inc trades at $88.9 (market cap $16.95B). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 4.4× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.08%). Which is the better fit depends on your goals.
| CP | ZBH | |
|---|---|---|
Market Cap | $73.98B | $16.95B |
Volume | 1,669,828 | 2,505,240 |
Sector | Industrials | Health |
52-Week High | $96.69 | $103.98 |
52-Week Low | $68.88 | $79.58 |
Enterprise Value | $91.36B | $24.02B |
Dividend Yield | 0.9% | 1.08% |
Typical Hold Time | — | 89 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zimmer Biomet (ZBH) trades at $88.49, down 1.33% today, with a bearish technical signal despite recent earnings beats. The company shows steady revenue growth to $8.23B in 2025, though net margins have compressed from 13.84% in 2023 to 8.56%. Analyst consensus is mixed with 40% buy ratings but a $103.11 price target suggesting 16.5% upside. Recent news highlights dividend declarations and leadership promotions aimed at accelerating commercial transformation.
ZBH presents a value opportunity with reasonable valuation multiples (P/E 21.48, P/S 2.04) and consistent earnings outperformance, but faces headwinds from margin pressure and technical weakness. The stock's investment case hinges on execution of growth initiatives amid competitive and debt-related risks, with current levels offering entry near support.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →